JP2008534537A5 - - Google Patents

Download PDF

Info

Publication number
JP2008534537A5
JP2008534537A5 JP2008503404A JP2008503404A JP2008534537A5 JP 2008534537 A5 JP2008534537 A5 JP 2008534537A5 JP 2008503404 A JP2008503404 A JP 2008503404A JP 2008503404 A JP2008503404 A JP 2008503404A JP 2008534537 A5 JP2008534537 A5 JP 2008534537A5
Authority
JP
Japan
Prior art keywords
formula
represents hydrogen
hydroxy
solvate
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008503404A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008534537A (ja
Filing date
Publication date
Priority claimed from DE102005014247A external-priority patent/DE102005014247A1/de
Application filed filed Critical
Publication of JP2008534537A publication Critical patent/JP2008534537A/ja
Publication of JP2008534537A5 publication Critical patent/JP2008534537A5/ja
Withdrawn legal-status Critical Current

Links

JP2008503404A 2005-03-30 2006-03-21 抗菌性アミドマクロサイクルvi Withdrawn JP2008534537A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005014247A DE102005014247A1 (de) 2005-03-30 2005-03-30 Antibakterielle Amid-Makrozyklen VI
PCT/EP2006/002564 WO2006103009A1 (de) 2005-03-30 2006-03-21 Antibakterielle amid-makrozyklen vi

Publications (2)

Publication Number Publication Date
JP2008534537A JP2008534537A (ja) 2008-08-28
JP2008534537A5 true JP2008534537A5 (cg-RX-API-DMAC7.html) 2009-04-30

Family

ID=36228560

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008503404A Withdrawn JP2008534537A (ja) 2005-03-30 2006-03-21 抗菌性アミドマクロサイクルvi

Country Status (7)

Country Link
US (1) US20080300231A1 (cg-RX-API-DMAC7.html)
EP (1) EP1866291B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008534537A (cg-RX-API-DMAC7.html)
CA (1) CA2602743A1 (cg-RX-API-DMAC7.html)
DE (2) DE102005014247A1 (cg-RX-API-DMAC7.html)
ES (1) ES2327444T3 (cg-RX-API-DMAC7.html)
WO (1) WO2006103009A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10358824A1 (de) 2003-12-16 2005-07-21 Bayer Healthcare Ag Antibakterielle Makrozyklen mit substituiertem Biphenyl
DE102005032781A1 (de) * 2005-07-14 2007-01-18 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Markozyklen VII
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
BR112015011697A2 (pt) * 2012-11-21 2017-07-11 Rqx Pharmaceuticals Inc antibióticos macrocíclicos de amplo espectro
EP3145944B1 (en) 2014-05-20 2021-05-05 RQX Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
RU2761476C2 (ru) 2015-11-20 2021-12-08 АрКьюИкс ФАРМАСЬЮТИКЭЛС, ИНК. Макроциклические антибиотики широкого спектра действия
HRP20231497T8 (hr) 2019-05-28 2024-08-02 F. Hoffmann-La Roche Ag Makrociklični antibiotici širokog spektra

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452136A (en) * 1968-04-17 1969-06-24 American Cyanamid Co Antibiotic af283 and production thereof
FR2720066B1 (fr) * 1994-05-20 1996-06-28 Rhone Poulenc Rorer Sa Peptides antagonistes de la neurotensine.
DE10226921A1 (de) * 2002-06-17 2003-12-24 Bayer Ag Antibakterielle Amid-Makrozyklen
DE10234422A1 (de) * 2002-07-29 2004-02-12 Bayer Ag Antibakterielle Ester-Makrozyklen
CA2540646A1 (en) * 2003-10-01 2005-04-14 Bayer Healthcare Ag Antibacterial amide macrocycles
DE10358824A1 (de) * 2003-12-16 2005-07-21 Bayer Healthcare Ag Antibakterielle Makrozyklen mit substituiertem Biphenyl
DE102005014240A1 (de) * 2004-09-24 2006-03-30 Bayer Healthcare Ag Antibakterielle Amid-Makrozyklen IV

Similar Documents

Publication Publication Date Title
JP5064024B2 (ja) イマチニブの製造方法、及び該方法により製造されたイマチニブ
JP2007501809A5 (cg-RX-API-DMAC7.html)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2006526031A5 (cg-RX-API-DMAC7.html)
JP2009502743A5 (cg-RX-API-DMAC7.html)
JP2008526999A5 (cg-RX-API-DMAC7.html)
WO2019177975A1 (en) Antibiotics effective for gram-negative pathogens
MXPA04005209A (es) Antagonistas del receptor de adenosina a2a.
JP2011505356A5 (cg-RX-API-DMAC7.html)
TW200738698A (en) Organic compounds
MY145924A (en) Antibacterial quinoline derivatives
RU2409588C2 (ru) Бактерицидные содержащие амидные группы макроциклы v
JP2008534537A5 (cg-RX-API-DMAC7.html)
JP2005502636A5 (cg-RX-API-DMAC7.html)
JP2005501870A5 (cg-RX-API-DMAC7.html)
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
JP2008534540A5 (cg-RX-API-DMAC7.html)
JP2005527479A5 (cg-RX-API-DMAC7.html)
JP2006510659A5 (cg-RX-API-DMAC7.html)
NO20044531L (no) Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom
MY147404A (en) Process for preparation of n-benzoyl-staurosporine
JP2008544975A5 (cg-RX-API-DMAC7.html)
JP2008514561A5 (cg-RX-API-DMAC7.html)
JP2005526073A5 (cg-RX-API-DMAC7.html)
ZA200704584B (en) New 3-Phenylpropionic acid derivatives for the treatment of diabetes